JoVE Logo
Faculty Resource Center

Sign In

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

DOI :

10.3791/54440-v

September 19th, 2016

September 19th, 2016

10,325 Views

1Department of Microbiology, University of Zaragoza

We herein detail the methodology followed to compare protective efficacy and lung immune response induced by intranasal and subcutaneous immunization with BCG in mouse model. Our results show the benefits of pulmonary vaccination and suggest a role for IL17-mediated response in vaccine-induced protection.

Tags

Protective Efficacy

-- Views

Related Videos

article

Multicolor Flow Cytometry Analyses of Cellular Immune Response in Rhesus Macaques

article

Seven Steps to Stellate Cells

article

Quantitative Measurement of the Immune Response and Sleep in Drosophila

article

Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice

article

Cecal Ligation and Puncture-induced Sepsis as a Model To Study Autophagy in Mice

article

Using RNA-interference to Investigate the Innate Immune Response in Mouse Macrophages

article

The Utilization of Oropharyngeal Intratracheal PAMP Administration and Bronchoalveolar Lavage to Evaluate the Host Immune Response in Mice

article

Intranasal Administration of Recombinant Influenza Vaccines in Chimeric Mouse Models to Study Mucosal Immunity

article

Transformation of Probiotic Yeast and Their Recovery from Gastrointestinal Immune Tissues Following Oral Gavage in Mice

article

Lung microRNA Profiling Across the Estrous Cycle in Ozone-exposed Mice

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved